HGF/c-Met signaling is a well-established oncogenic pathway: c-Met is amplified or overexpressed in multiple cancers (gastric, lung, renal, hepatocellular) HGF/c-Met activation promotes tumor cell proliferation, survival, invasion, and metastasis c-Met inhibitors are FDA-approved cancer drugs (cabozantinib, crizotinib, capmatinib) A compound that potentiates HGF/c-Met signaling raises theoretical concerns about promoting tumor growth or transformation with chronic use
Buying peptides online marketed for research use only and using them on yourself is not legal, because theyre unapproved drugs not intended for human use
Gonadotropin Modulation Peptides can affect pituitary release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which directly regulate follicle growth and ovulation
Plays a key role in maintaining healthy nervous system function and supports the formation of myelin sheaths that protect nerve fibers
(Lausanne) 12 , 721135 (2021)